14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.17 $7.64 Wednesday, 24th Apr 2024 FATE stock ended at $4.30. This is 5.29% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.75% from a day low at $4.17 to a day high of $4.66.
90 days $4.17 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jun 07, 2021 $75.68 $78.02 $73.16 $77.00 1 368 139
Jun 04, 2021 $68.28 $74.98 $68.05 $72.79 1 511 388
Jun 03, 2021 $68.13 $69.01 $65.13 $67.25 924 357
Jun 02, 2021 $72.09 $72.79 $66.76 $68.94 1 518 247
Jun 01, 2021 $76.86 $77.00 $71.85 $72.46 897 267
May 28, 2021 $76.42 $79.25 $76.11 $76.60 578 347
May 27, 2021 $77.24 $77.24 $74.50 $76.25 639 601
May 26, 2021 $75.33 $76.87 $73.05 $76.47 617 661
May 25, 2021 $74.00 $76.70 $74.00 $74.74 490 597
May 24, 2021 $75.04 $75.72 $73.10 $74.03 493 811
May 21, 2021 $78.37 $78.75 $73.75 $73.81 578 617
May 20, 2021 $76.54 $78.86 $75.64 $77.25 966 879
May 19, 2021 $75.05 $78.71 $73.80 $75.32 774 308
May 18, 2021 $77.11 $82.82 $76.05 $78.03 724 641
May 17, 2021 $74.49 $77.95 $73.62 $76.34 963 623
May 14, 2021 $71.42 $79.00 $71.40 $76.70 1 706 345
May 13, 2021 $73.70 $76.59 $68.27 $71.51 1 268 680
May 12, 2021 $75.95 $77.96 $71.63 $72.29 1 309 010
May 11, 2021 $71.21 $80.99 $70.16 $78.00 1 518 947
May 10, 2021 $75.41 $76.84 $73.20 $75.71 1 445 711
May 07, 2021 $79.40 $82.80 $75.92 $76.49 786 176
May 06, 2021 $73.50 $76.72 $70.25 $76.55 2 043 209
May 05, 2021 $79.93 $81.75 $76.59 $77.73 602 271
May 04, 2021 $83.85 $83.85 $77.79 $79.73 829 461
May 03, 2021 $89.84 $90.16 $84.75 $85.11 761 919
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT